Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A ground-breaking study in Bangladesh co-lead by MORU has found that using data from mobile phone networks to track the movement of people across the country can help predict where outbreaks of diseases such as malaria are likely to occur, enabling health authorities to take preventative measures.

Simple buildings in Chimbuk, Bangladesh

Head of Epidemiology, Richard Maude, was co-PI for the study and designed it together with co-PI Caroline Buckee from Harvard University. MORU Epidemiology and longstanding MORU collaborators from Chittagong Medical College (CMC) led by co-PI Md Amir Hossain set up and ran the field studies to collect the demographic and travel surveys and blood samples from people with malaria, negotiated permissions to access the cellphone data and liaised with the partners in Bangladesh including the National Malaria Elimination Programme who contributed national surveillance data to the project. 

Hospital ward in BangladeshHospital ward in BangladeshDidar Uddin was field site coordinator on the ground in Bangladesh supported by CMC. Ipsita Sinha and Sazid Ibna Zaman contributed to the data analysis and did the data management for the study together with the CTSG team. Specimen management was supported by WWARN and the blood samples were analysed at the Sanger Institute in the UK as part of the GenReMekong project led by Olivo Miotto.

This publication is the first of a series of papers from this study. A second paper written by Ipsita with a more detailed analysis of the travel surveys is currently under review. The study was funded by grants from the Bill and Melinda Gates Foundation, National Institute of General Medical Sciences and the Medical Research Council.

Read this story on BBC News.

Similar stories

New antibiotic combination speeds recovery from severe scrub typhus, which infects 1 million people per year

Treating patients ill with severe scrub typhus – a life-threatening infection that kills tens of thousands of people a year - with a combination of intravenous antibiotics doxycycline and azithromycin is significantly more effective than the current monotherapy of using either drug alone, say researchers in a study published in the New England Journal of Medicine (NEJM).

Watch our webinar - Radical cure of vivax malaria: can we do better?

The three presentations and expert discussion by Dr Rob Commons, Dr Alison Roth and Dr James Watson, chaired by Professor Sir Nicholas White (Mahidol Oxford Research Unit) and Dr Chau Nguyen Hoang (Oxford University Clinical Research Unit), are now available.

Study supports evidence ivermectin not effective to treat COVID-19

21 Feb 2023 Oxford UK - High doses of the drug ivermectin, controversially recommended by some high-profile political and media figures during the COVID-19 pandemic, is ineffective at treating the COVID-19 virus, say University of Oxford-affiliated researchers in a study published today in eLife.

Phase II Malaria vaccine trial begins in Thailand

The Mahidol Oxford Tropical Medicine Research Unit (MORU) has begun a Phase II trial to demonstrate that R21/matrix M is well-tolerated and immunogenic when administered with the antimalarial drug combination.

Pilot study detects diverse DNA in ingredients of falsified tablets

A recent multidisciplinary pilot study, originating from LOMWRU and the Medicine Quality Research Group of IDDO and MORU, investigated whether bacterial, plant, fungal and animal DNA in the ingredients and from the environment (eDNA) could be detected from falsified (aka counterfeit) tablets.

Ricardo Aguas awarded Associate Professorship

We are delighted to announce that Ricardo Aguas has been awarded the Associate Professor title, in recognition of his achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.